Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Other financing activities (2016 - 2022)

Historic Other financing activities for Usana Health Sciences (USNA) over the last 12 years, with Q4 2022 value amounting to -$3.0 million.

  • Usana Health Sciences' Other financing activities changed N/A to -$3.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $46000.0 for FY2021, which is 9768.5% down from last year.
  • Usana Health Sciences' Other financing activities amounted to -$3.0 million in Q4 2022.
  • Usana Health Sciences' 5-year Other financing activities high stood at $4.2 million for Q2 2022, and its period low was -$3.0 million during Q4 2022.
  • Over the past 5 years, Usana Health Sciences' median Other financing activities value was $175500.0 (recorded in 2019), while the average stood at $408555.6.
  • In the last 5 years, Usana Health Sciences' Other financing activities surged by 35876.62% in 2019 and then crashed by 72131.15% in 2021.
  • Quarter analysis of 5 years shows Usana Health Sciences' Other financing activities stood at $433000.0 in 2018, then fell by 29.56% to $305000.0 in 2019, then tumbled by 85.9% to $43000.0 in 2020, then surged by 39.53% to $60000.0 in 2021, then crashed by 5168.33% to -$3.0 million in 2022.
  • Its last three reported values are -$3.0 million in Q4 2022, $301000.0 for Q3 2022, and $4.2 million during Q2 2022.